Value
7.5/10data confidence 83%| Component | Sub-score |
|---|---|
| P/S | 8.6 |
| EV/EBITDA | 2.3 |
| Fwd P/E | 9.4 |
| PEG | 8.2 |
| Analyst target | 9.0 |
- ▸Forward P/E: 9.4x
- ▸PEG: 0.79
- ▸Attractively valued
ALB · Why this verdict
Why Albemarle (ALB) is rated BUY WAIT
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictBUY WAIT
Overall score6.4/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis
Engine thesis — one sentence
Albemarle is posting strong earnings beats and 33% revenue growth with positive price momentum — but below-average business quality, 83% foreign revenue exposure, an asymmetry ratio just below the threshold, and a recent executive departure flag suggest patience is warranted before adding aggressively at current levels.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
The stock is above its 200-day moving average with rising on-balance volume and a strong MACD — technical conditions consistent with institutional buying interest supporting the price trend. Momentum breakdown | On-balance volume continuing to rise over the next three months, with the stock remaining above its 200-day moving average, would confirm the trend is intact. | ↑Improving |
| CounterThe setup is range-bound with RSI at 46, suggesting mid-range conditions that could resolve either direction; the asymmetry ratio falling just below the minimum threshold indicates the technical configuration is not yet strong enough for a high-conviction entry. | ||
Three of the past four quarters produced earnings beats averaging more than 76% above consensus, while revenue is growing at 33% year-over-year — placing the company at the top of its peer group for growth and demonstrating consistent ability to exceed expectations off a low base. Catalyst breakdown | Continued positive EPS surprise for the next two reporting periods and revenue growth sustaining above 20% would confirm the earnings recovery is durable. | ↑Improving |
| CounterThe single miss came in at 8.6% below estimates, and specialty chemical revenue can be volatile given commodity input swings and customer inventory cycles that can abruptly reverse recent momentum. | ||
At 83% of net sales derived from foreign countries, currency movements, tariff changes, and geopolitical disruption can materially impair reported results in ways that domestically focused specialty chemical producers do not face. Bear case | Foreign sales concentration declining below 70% or the company announcing material domestic revenue growth would reduce this geographic risk. | ↓Deteriorating |
| CounterInternational presence across multiple geographies can be diversifying rather than concentrating if no single country dominates the foreign mix — the reported percentage alone does not reveal how the risk is distributed. | ||
Despite impressive earnings beats, underlying business quality is below par — return on assets is negligible and gross margin data is absent — leaving uncertainty about whether recent results reflect durable fundamental improvement or a cyclical conditions bounce. Key risks | Return on assets rising above 3% and gross margin becoming visible and positive for two consecutive quarters would signal the improvement is structural. | ↓Deteriorating |
| CounterA Piotroski F-Score of 8 out of 9 is a strong indicator of financial health that often leads quality indices by several quarters; the current quality shortfall may reflect measurement lag rather than genuine business weakness. | ||
The stock is above its 200-day moving average with rising on-balance volume and a strong MACD — technical conditions consistent with institutional buying interest supporting the price trend.
↑ImprovingMomentum breakdown
- Expectation
- On-balance volume continuing to rise over the next three months, with the stock remaining above its 200-day moving average, would confirm the trend is intact.
CounterThe setup is range-bound with RSI at 46, suggesting mid-range conditions that could resolve either direction; the asymmetry ratio falling just below the minimum threshold indicates the technical configuration is not yet strong enough for a high-conviction entry.
Three of the past four quarters produced earnings beats averaging more than 76% above consensus, while revenue is growing at 33% year-over-year — placing the company at the top of its peer group for growth and demonstrating consistent ability to exceed expectations off a low base.
↑ImprovingCatalyst breakdown
- Expectation
- Continued positive EPS surprise for the next two reporting periods and revenue growth sustaining above 20% would confirm the earnings recovery is durable.
CounterThe single miss came in at 8.6% below estimates, and specialty chemical revenue can be volatile given commodity input swings and customer inventory cycles that can abruptly reverse recent momentum.
At 83% of net sales derived from foreign countries, currency movements, tariff changes, and geopolitical disruption can materially impair reported results in ways that domestically focused specialty chemical producers do not face.
↓DeterioratingBear case
- Expectation
- Foreign sales concentration declining below 70% or the company announcing material domestic revenue growth would reduce this geographic risk.
CounterInternational presence across multiple geographies can be diversifying rather than concentrating if no single country dominates the foreign mix — the reported percentage alone does not reveal how the risk is distributed.
Despite impressive earnings beats, underlying business quality is below par — return on assets is negligible and gross margin data is absent — leaving uncertainty about whether recent results reflect durable fundamental improvement or a cyclical conditions bounce.
↓DeterioratingKey risks
- Expectation
- Return on assets rising above 3% and gross margin becoming visible and positive for two consecutive quarters would signal the improvement is structural.
CounterA Piotroski F-Score of 8 out of 9 is a strong indicator of financial health that often leads quality indices by several quarters; the current quality shortfall may reflect measurement lag rather than genuine business weakness.
Per-dimension breakdown
Quality
4.1/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 0.0 |
| ROA | 1.1 |
| Gross margin | 0.0 |
| Op margin | 9.9 |
| Net margin | 0.0 |
| Current ratio | 7.2 |
| Moat | 5.8 |
| Piotroski F | 8.9 |
- ▸Strong Piotroski F-Score: 8/9
Growth
10.0/10data confidence 33%| Component | Sub-score |
|---|---|
| Rev growth | 10.0 |
- ▸Strong growth: 33% YoY
Momentum
3.2/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 3.0 |
| MACD | 10.0 |
| OBV | 1.0 |
| MA position | 2.2 |
| Volume | 0.0 |
- ▸Capitulation risk (RSI 22, below 200MA)
- ▸Volume distribution (falling OBV)
- ▸Below 200-MA but MA still rising (+6.0%/30d) — pullback in uptrend, not confirmed weakness
Sentiment
7.6/10data confidence 100%| Component | Sub-score |
|---|---|
| LLM sentiment | 5.8 |
| Analyst rating | 7.5 |
| Price target | 9.7 |
- ▸Analyst upside: 61%
Insider
5.9/10data confidence 100%| Component | Sub-score |
|---|---|
| materiality | 4.5 |
| insider conviction | 2.0 |
| holder change | 10.0 |
| notable moves | 7.0 |
- ▸Modest insider selling — $3,011,766 (0.022% of mkt cap)
- ▸Institutions accumulating
Peer rank
5.7/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 3.5 |
| quality rank | 1.8 |
| growth rank | 8.8 |
- ▸Industry growth leader
- ▸Conservative debt levels
Technical
5.7/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 8.1 |
| support resistance | 8.9 |
| 52w position | 0.8 |
| gap | 5.0 |
Risk (lower is worse)
5.9/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 10.0 |
| days to cover | 10.0 |
| volatility | 1.8 |
| put call | 3.1 |
| implied vol | 1.7 |
| max pain risk | 7.0 |
| beta | 5.6 |
| debt equity | 9.2 |
| news risk | 5.0 |
- ▸Elevated put/call: 1.53
- ▸High IV: 70%
- ▸Concentration risks: 1 HIGH, 1 MED (10-K Item 1A — sized via position_sizing, validated via buy_confidence)
Catalyst
6.9/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 6.7 |
| earnings timing | 5.0 |
| surprise avg | 10.0 |
| dividend safety | 7.5 |
| news activity | 7.0 |
- ▸Strong earnings: 3B/1M
- ▸Earnings in 13 days
- ▸Dividend aristocrat: 1.4% yield
How the verdict was assembled
Engine trigger
Mixed signals. Hold existing position. | News modifier +2 (HOLD_IF_HOLDING → STRONG_BUY_WAIT).
Engine technical detail
verdict_path:
L4:PATH_F_HOLD_DEFAULT|L3:NEWS_MOD=+2|ENTRY_STICKY:PRIOR_STILL_VIABLEPassed (4)
- ASYMMETRY:5.2>=1.5
- INSIDER:OK
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
- MOMENTUM:3.2<4.5
Warning (2)
- 8K_CSUITE_CHANGE:5.02 (officer departure/appointment)
- EARNINGS_PROXIMITY:13d<=14d (soft)
Reward-to-Risk
5.23
Upside
+44.7%
Downside
8.5%
Sizing output
STARTER
Setup— — No clear chart pattern; technical signals are mixed
EdgeCatalyst-Driven — Earnings in 13d with 3/4 beat streak
SuitabilitySpeculative — Drawdown -46% (>40% off 52w high)
Investment implication
The default F-path HOLD fired without any positive-conviction gate triggering — no momentum acceleration, no quality+value crossover, no setup recognition. Highest-clear gate: ASYMMETRY:5.2>=1.5. Top dim: Growth at 10.0; weakest: Momentum at 3.2. The engine's read is one of pattern absence — no directional conviction in either direction at current asymmetry.
The strongest dimensions are Growth at 10.0, Sentiment at 7.6, and Value at 7.5; the weakest are Momentum at 3.2, Quality at 4.1, and Technical at 5.7. The V9 engine flagged 1 failed gate with 2 warnings, producing an asymmetric reward-to-risk of 5.23 and an engine sizing output of STARTER.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Strong Earnings Beats With Growth Leadership
Trip ifRevenue growth falls below 10% YoY for 2 consecutive quarters.
- P2Positive Momentum With Volume Accumulation
Trip ifStock breaks below the 200-day moving average and on-balance volume trends lower for more than 4 consecutive weeks.
- P3Geographic Concentration In Foreign Markets
Trip ifForeign revenue concentration falls below 60% for 2 consecutive reporting periods.
- P4Below Average Quality Amid Earnings Recovery
Trip ifReturn on assets rises above 4% for 2 consecutive quarters.